
Medicine
Landmark Alzheimer's Drug Approval Confounds Research Community
Many scientists say there is not enough evidence that Biogen’s aducanumab is an effective therapy for the disease

Many scientists say there is not enough evidence that Biogen’s aducanumab is an effective therapy for the disease

Multimillion dollar initiative prioritizes drug development over discovery of new molecules

Drug discovery is a daunting process that requires chemists to sift through millions of chemicals to find a single hit. DNA technology can dramatically speed up the search
Support science journalism.

Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account